The Ameridose Mobile App can be downloaded at no charge from Google Play or the Apple App Store. The App includes two levels of access in order to address varying needs within the hospital environment. The quick access feature can be used by all hospital staff, including on-floor nursing, without requiring a login. It allows lot-specific lookup for latex and preservative information as well as options for immediate communication with Ameridose Account Services. The App’s secure login service has additional features such as an associated product list view, order history and tracking, package inserts, product images, plus Live Chat™ to enable instant communication with Ameridose Account Services. Enhanced capabilities will be added on a regular basis.
“Ameridose strives to provide industry-leading convenience to our customers. So, it makes sense for Ameridose to make services accessible by mobile device, giving the customer more options for access and more flexibility as to where the access takes place. In addition, we know that on-floor access to information, such as latex and preservative content, can be critical in a hospital environment. We have designed our App to allow for expanded staff access to satisfy this significant hospital requirement. At Ameridose, our goal is to continuously examine and improve every aspect of our patient care and customer service,” stated Todd DeAngelis, Vice President of Innovation and Customer Experience for Ameridose.
Show less
Ameridose Issues Recall of All Products
October 31, 2012
|
October 31, 2012 Dear Customer: Ameridose is conducting a voluntary recall of any unexpired products remaining in circulation. This action is voluntary, and represents an expansion of our cooperation with the U.S. Food and Drug Administration and the Massachusetts Board of Registration in Pharmacy. During the course of its on-going inspection of our facility, FDA has notified Ameridose that it will be seeking improvements in Ameridose's sterility testing process. Ameridose and FDA agree that the use of injectible products that are not sterile can represent a serious hazard to health and could lead to life-threatening injuries and/or death. Ameridose has not received any adverse reports related to the products subject to this recall and neither Ameridose nor the FDA has identified impurities in any Ameridose products. Nevertheless, out of an abundance of caution, we are undertaking this recall to assure customers that when Ameridose products are shipped, they are fully in conformance with all of the FDA's recommendations. Products from Ameridose can be identified by markings that indicate Ameridose by name or by its company logo shown above. A complete list of all products subject to this recall can be accessed on-line at www.ameridose.com. If you have any Ameridose products on hand, immediately examine your inventory and quarantine products subject to this recall. This recall should be carried out to the user level. Please complete the attached form regarding the current status of these lot(s) and return the form to Ameridose by fax at 508-656-6596, or by email at amdservice@ameridose.com. We then will contact you to arrange for return of all materials. We thank you for your cooperation, and apologize for any inconvenience. If you have questions regarding this recall, please contact us at 888-820-0622. Sincerely, Ameridose, LLC 205 Flanders Road, Westborough, MA 01581 Email: amdservice@ameridose.com www.ameridose.com Ameridose Voluntary Product Recall Response Form Ameridose Voluntary Product Recall List |
Ameridose Mobile App Raises the Bar for Convenience and Patient Safety
October 05, 2012
Ameridose has launched its Ameridose Mobile App as yet another way to offer customers the very best in state-of-the-art convenience and patient safety. Customers are now able to access many Ameridose online services by way of smartphone or tablet.
Show more
Show more
2 records found.